OCCHIPINTI, SERGIO
 Distribuzione geografica
Continente #
NA - Nord America 1439
EU - Europa 1132
AS - Asia 395
AF - Africa 39
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 2
Totale 3016
Nazione #
US - Stati Uniti d'America 1413
IT - Italia 367
CN - Cina 255
SE - Svezia 245
IE - Irlanda 110
FR - Francia 108
AT - Austria 59
DE - Germania 50
FI - Finlandia 49
UA - Ucraina 34
SN - Senegal 32
VN - Vietnam 32
GB - Regno Unito 31
KR - Corea 28
CA - Canada 24
BE - Belgio 23
PL - Polonia 20
IN - India 19
JP - Giappone 13
HK - Hong Kong 10
TW - Taiwan 10
ES - Italia 9
RU - Federazione Russa 7
SG - Singapore 6
PK - Pakistan 5
AU - Australia 4
GR - Grecia 4
MY - Malesia 4
RO - Romania 4
CH - Svizzera 3
DZ - Algeria 3
EU - Europa 3
TR - Turchia 3
IL - Israele 2
IR - Iran 2
MU - Mauritius 2
MX - Messico 2
NL - Olanda 2
A1 - ???statistics.table.value.countryCode.A1??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
BD - Bangladesh 1
BG - Bulgaria 1
BR - Brasile 1
BY - Bielorussia 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EG - Egitto 1
HU - Ungheria 1
ID - Indonesia 1
NZ - Nuova Zelanda 1
PE - Perù 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TN - Tunisia 1
Totale 3016
Città #
Chandler 218
Torino 210
Houston 135
Beijing 117
Dublin 108
Ann Arbor 96
Fairfield 90
Nyköping 73
Dearborn 65
Vienna 58
Wilmington 49
Ashburn 47
Villeurbanne 47
Woodbridge 42
Fremont 35
Cambridge 34
Princeton 34
Medford 33
Seattle 31
Redwood City 27
Pisa 26
Jacksonville 25
Brussels 19
Dong Ket 18
Warsaw 18
Shanghai 17
Düsseldorf 14
Nanjing 14
Wuhan 13
Boston 12
Boardman 10
Menlo Park 10
Jinan 9
Milan 9
Piemonte 9
Grugliasco 8
Hefei 8
Taipei 8
Munich 7
Norwalk 7
Toronto 7
Turin 7
Alcobendas 6
Guangzhou 6
Ottawa 6
Chengdu 5
San Diego 5
Chongqing 4
Falls Church 4
Islamabad 4
Kunming 4
Montréal 4
Mumbai 4
Phoenix 4
Xian 4
Zhengzhou 4
Camerino 3
Changchun 3
Evanston 3
Hangzhou 3
Nanchang 3
Nanning 3
Napoli 3
New York 3
Nicola 3
Patna 3
Pittsburgh 3
Tokyo 3
Ahmedabad 2
Auburn Hills 2
Baltimore 2
Baotou 2
Barak 2
Bardhaman 2
Bensalem 2
Canberra 2
Changsha 2
Cleveland 2
Crick 2
Denver 2
Deva 2
Gaithersburg 2
Gravina In Puglia 2
Lanzhou 2
Lindome 2
Louvain 2
Macerata 2
Markópoulo 2
Moncalieri 2
Naples 2
Nürnberg 2
Rochester 2
Rome 2
Trieste 2
Upper Marlboro 2
Vancouver 2
Aberdeen 1
Aberystwyth 1
Albuquerque 1
Alexandria 1
Totale 1984
Nome #
Enhanced cytotoxic effect of camptothecin nanosponges in anaplastic thyroid cancer cells in vitro and in vivo on orthotopic xenograft tumors 301
Regulation of Langerhans cell functions in a hypoxic environment 299
Solid lipid nanoparticles of cholesteryl butyrate inhibit the proliferation of cancer cells in vitro and in vivo models. 183
Chimeric Rat/Human HER2 Efficiently Circumvents HER2 Tolerance in Cancer Patients. 155
PDGF enhances the protective effect of adipose stem cell-derived extracellular vesicles in a model of acute hindlimb ischemia 135
Antitumor effect of nanosponges-encapsulated camptothecin in human prostate tumors 134
Antitumor effect of nanosponge-encapsulated camptothecin in human prostate tumors 124
Triggering of B7h by the ICOS Modulates Maturation and Migration of Monocyte-Derived Dendritic Cells 108
Phage-based anti-HER2 vaccination can circumvent immune tolerance against breast cancer. 108
B7h triggering inhibits the migration of tumor cell lines. 101
In Vitro and In Vivo Therapeutic Evaluation of Camptothecin-Encapsulated β-Cyclodextrin Nanosponges in Prostate Cancer 101
Neutralization of IL-10 And TGF beta 1 rescues T cells from tolerogenic mechanisms induced by HER2 vaccine in cancer patients 100
Effect of Camptothecin nanosponges on anaplastic thyroid cancer models 93
Detection of urinary prostate specific antigen by a lateral flow biosensor predicting repeat prostate biopsy outcome 92
DNA vaccines coding for chimeric human/rat HER2 as innovative immunotherapeutic tools for the treatment of HER2+ cancer patients 89
High Mobility Group Box 1 (hmgb1) Expands CD4+CD25+Foxp3+ T Cells and Increases the Expression of CD39 86
Camptothecin in nanosponges as new therapeutic delivery agent in prostate cancer: in vitro and in vivo evaluation 84
Erbb2 DNA vaccine combined with Treg cell deletion enhances antibody response and reveals latent low-avidity T cells. Potential and limits of its therapeutic efficacy. 81
Cytotoxic effect of Camptothecin nanosponges in anaplastic thyroid cancer cells in vitro and in orthotopic xenograft tumors in vivo 77
Dendritic cells transfected with ErbB-2 rat/human hybrid plasmid elicit an effective T cells response in ErbB-2+ cancer patients 74
Erbb2 DNA vaccine combined with regulatory T cell deletion enhances antibody response and reveals latent low-avidity T cells: potential and limits of its therapeutic efficacy. 71
Triggering of B7h by the inducible costimulator modulates maturation and migration of monocyte-derived dendritic cells 70
Cytotoxic effect of Camptothecin nanosponges in anaplastic thyroid cancer cells in vitro and in vivo in orthotopic xenograft tumors 64
B7H triggering inhibits migration of tumor cell lines 63
B7h triggering inhibits the migration of tumor cell lines x 62
Dendritic cells transfected with ErbB2 rat/human hybrid plasmid elicit an effective T cells response in ErbB2+ cancer patients 61
Dendritic cells transfected with DNA encoding ErbB2 rat/human chimeric plasmids are able to activate in vitro a specific T cell response in ErbB2+ cancer patients 59
Effective T cells response can be elicited in ErbB-2+ cancer patients by ErbB-2 rat/human hybrid plasmid transfection of dendritic cells 58
Erbb2 rat/human hybrid vaccine eludes self-antigen tolerance and elicits an effective t cells response in erbb2 cancer patients 58
Low levels of urinary psa better identify prostate cancer patients 58
Exploring chitosan-shelled nanobubbles to improve HER2 + immunotherapy via dendritic cell targeting 10
Urinary Zinc Loss Identifies Prostate Cancer Patients 7
Totale 3166
Categoria #
all - tutte 5481
article - articoli 0
book - libri 0
conference - conferenze 2449
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7930


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/20186 0000 00 00 0006
2018/2019274 1441614 611 1046 16376139
2019/2020530 42111960 41122 6029 47513216
2020/2021392 34363643 4026 2620 37162949
2021/2022522 13291161 3713 3642 185913370
2022/2023635 53912171 41159 4540 6514341
Totale 3166